Molecular Partners Ag (MOLN) Return on Sales (2020 - 2026)
Molecular Partners Ag (MOLN) posted quarterly Return on Sales of 0.01% for Q1 2026, little changed year-on-year from 0.01% in Q1 2025, and down 100.07% on a QoQ basis from 14.39% in Q4 2025.
Molecular Partners Ag (MOLN) Return on Sales (2020 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Return on Sales for 7 consecutive years, with 0.01% the latest figure, recorded in Q1 2026.
- Quarterly Return on Sales changed 0.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 220.36% (up 22036.0% YoY) and the FY2025 annual result came in at 11267.13%, down 1126702.0% from the prior year.
- Return on Sales eased to 0.01% in Q1 2026 per MOLN's latest filing, from 14.39% in the prior quarter.
- Over the last five years, Return on Sales for MOLN reached as high as 14.39% in Q4 2025 and fell as low as 97.24% in Q2 2024.
- A 5-year average of 4.92% and a median of 0.01% in 2026 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2024 — Return on Sales plunged 9686 bps — and 2025, when it surged 9723 bps.
- Year by year, Return on Sales stood at 0.01% in 2022, then slumped by 1207 bps to 0.09% in 2023, then surged by 100 bps to 0.0% in 2024, then surged by 13113852 bps to 14.39% in 2025, then plunged by 100 bps to 0.01% in 2026.
- According to Business Quant data, Return on Sales over the past three periods registered 0.01%, 14.39%, and 0.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Molecular Partners Ag | 147.97 Mn | 147.97 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | 14.39% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | -0.24% |
| Jun 30, 2024 | -97.24% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | -0.09% |
| Sep 30, 2023 | -0.05% |
| Jun 30, 2023 | -0.39% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.01% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.01% |
| Dec 31, 2021 | -0.07% |
| Sep 30, 2021 | -0.03% |
| Jun 30, 2021 | 0.00% |